We are live on ! Find out more
CV

Clarus Ventures Portfolio holdings

AUM $425M
1-Year Est. Return 26.13%
This Fund
S&P 500
This Quarter Est. Return
-17.2%
1 Year Est. Return
+26.13%
3 Year Est. Return
+70.29%
5 Year Est. Return
+162.11%
10 Year Est. Return
–
AUM
$251M
AUM Growth
-$31M
Cap. Flow
+$18.3M
Cap. Flow %
7.31%
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
+$18.3M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AERI
1
DELISTED
Aerie Pharmaceuticals
AERI
$71.8M 28.63%
3,468,495
– –
ISEE
2
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$60.5M 24.15%
1,554,744
– –
NSTG
3
DELISTED
NanoString Technologies, Inc.
NSTG
$43.3M 17.28%
3,959,440
– –
OXFD
4
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$39.4M 15.71%
2,579,062
– –
TLOG
5
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
$19.3M 7.71%
4,644,705
– –
VBIV
6
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$16.3M 6.51%
+165,703
New +$18.3M

Similar funds

LLC
Latimer Light Capital New York $432M AUM 25.5% 1-Year Est. Return
VIA
Vantage Investment Advisors State College, Pennsylvania $477M AUM 17.38% 1-Year Est. Return
SPC
Salient Private Client Houston, Texas $513M AUM 10.97% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
CG
Clinton Group New York $279M AUM 4.76% 1-Year Est. Return
AAM
Amerigo Asset Management George Town, Cayman Islands $254M AUM 115.73% 1-Year Est. Return
SE
Summit Equities Parsippany, New Jersey $601M AUM 9.74% 1-Year Est. Return
CA
Cynosure Advisors Salt Lake City, Utah $238M AUM 4% 1-Year Est. Return

Clarus Ventures's Q3 2014 Portfolio in Review

As of Q3 2014, Clarus Ventures held 6 positions worth $251M, down 11% from $282M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Clarus Ventures deployed $18.3M of net new capital in Q3 2014, opening 1 new position. Its largest new stake was VBI Vaccines, Inc. New Common Stock (Canada): 165,703 shares worth $16.3M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Clarus Ventures's largest Q3 2014 buy was VBI Vaccines, Inc. New Common Stock (Canada): 165,703 shares worth $16.3M.
  • Clarus Ventures's ten largest holdings make up 100% of its $251M portfolio in Q3 2014.
  • Clarus Ventures opened 1 new position and closed 0 in Q3 2014.
  • Clarus Ventures's portfolio value fell 11% quarter-over-quarter to $251M.

Based on Clarus Ventures's 13F filing for Q3 2014, filed 13 Nov 2014.